Markets:

Overview

News

Currencies

International

Treasuries

Pfizer (NY:PFE)

25.81 +0.13 (+0.51%)

Official Closing Price Updated: 7:00 PM EDT, May 11, 2026 Add to My Watchlist

Quote

Overview Detailed Quote Charting Historical Prices

News

All News News Headlines Press Releases

Research

Quarterly Reports Insider Filings Other Filings

Press Releases about Pfizer

< Previous 1 2 3 4 5 6 7 8 9

...

40 41 Next >

BioMedNewsBreaks — SureNano Science Ltd. (CSE: SURE) (OTCQB: SURNF) Advances Next-Generation GLP-1 Candidate as Obesity Drug Market Expands Rapidly

Today 10:11 EDT

Via Investor Brand Network

The Next Generation of the GLP-1 Revolution Is Already Underway

Today 8:30 EDT

From BioMedWire

Via GlobeNewswire

What Are Horizontal Mergers and Acquisitions?

May 08, 2026

Via BusinesNews Wire

Topics Economy

Pfizer Reports Strong First-Quarter Results And Reaffirms 2026 Guidance

May 05, 2026

From Pfizer Inc.

Via Business Wire

Poets&Quants™ Names Best & Brightest MBAs of 2026

May 05, 2026

May 5, 2026 -- Annual feature celebrates graduating business students for campus impact and professional achievement

Via 24-7 Press Release

Pfizer’s ELREXFIO Significantly Improves Progression-Free Survival for Double-Class Exposed Patients with Relapsed or Refractory Multiple Myeloma

April 29, 2026

From Pfizer Inc.

Via Business Wire

Pfizer Reaches Three Settlement Agreements for VYNDAMAX

April 28, 2026

From Pfizer Inc.

Via Business Wire

Pfizer Declares Second-Quarter 2026 Dividend

April 22, 2026

From Pfizer Inc.

Via Business Wire

Pfizer Showcases Oncology Innovation and Next-Generation Pipeline at ASCO 2026

April 21, 2026

From Pfizer Inc.

Via Business Wire

Dividend Stock Guru Unveils High Yield Dividend Stock Research Reports

April 13, 2026

Via PRLog

Pfizer Invites Shareholders to View and Listen to Webcast of April 23 Virtual 2026 Annual Meeting of Shareholders

April 09, 2026

From Pfizer Inc.

Via Business Wire

Telix Strengthens Board with Additional Director Appointments

April 08, 2026

From Telix Pharmaceuticals Limited

Via GlobeNewswire

OS Therapies Appoints Craig Eagle, MD as Strategic Advisor

April 08, 2026

Senior leadership roles at Guardant Health, Genentech and PfizerRegulatory, clinical and commercial expertise in therapeutics and biomarkersWill assist with osteosarcoma...

Via Newsfile

AI-Enhanced Robotics in Pharma Manufacturing Signals Major Efficiency, Margin Expansion Opportunities

April 07, 2026

From AINewsWire

Via GlobeNewswire

Pfizer Invites Public to View and Listen to Webcast of May 5 Conference Call with Analysts

March 24, 2026

From Pfizer Inc.

Via Business Wire

Pfizer and Valneva Announce Lyme Disease Vaccine Candidate Demonstrates Strong Efficacy in Phase 3 VALOR Trial

March 23, 2026

From Pfizer Inc.

Via Business Wire

Pfizer Recommends Shareholders Reject the Mini-Tender Offer by Tutanota LLC

March 20, 2026

From Pfizer Inc.

Via Business Wire

TALZENNA Plus XTANDI Significantly Improves Radiographic Progression-Free Survival in Metastatic Prostate Cancer

March 19, 2026

From Pfizer Inc.

Via Business Wire

Pfizer Announces Positive Topline Phase 2 Results for Next-Generation CDK4 Inhibitor, Atirmociclib, in Second-Line Metastatic Breast Cancer

March 17, 2026

From Pfizer Inc.

Via Business Wire

Rushing Headlong: Health IT's Legacy and the Road to Responsible AI Named 2025 Foreword INDIES Book of the Year Awards Finalist

March 16, 2026

Via PRLog

Topics Artificial Intelligence

Pfizer’s Phase 2 Study of Trispecific Antibody Positive in Moderate to Severe Atopic Dermatitis

March 09, 2026

From Pfizer Inc.

Via Business Wire

TechMediaBreaks – ParaZero Technologies Ltd. (NASDAQ: PRZO) Appoints Bat-Sheva Noy as Vice President of Global Sales

March 04, 2026

Via Investor Brand Network

PADCEV™ + Keytruda® Cuts Risk of Recurrence or Death by Nearly 50% in Cisplatin-Eligible Muscle-Invasive Bladder Cancer

February 27, 2026

From Pfizer Inc.

Via Business Wire

U.S. FDA Grants Full Approval to Pfizer’s BRAFTOVI Combination Regimen in First-Line Metastatic Colorectal Cancer

February 24, 2026

From Pfizer Inc.

Via Business Wire

TinyGemsBreaks – Helus Pharma(TM) (NASDAQ: HELP) (Cboe CA: HELP) Appoints Dr. Freda Lewis-Hall to Board and Scientific Advisory Committee Chair

February 24, 2026

Via Investor Brand Network

Next-Generation Psychiatric Therapies Target Massive $40B+ Market Opportunity

February 24, 2026

EQNX::TICKER_START (NASDAQ:HELP),(CBOE:HELP),(NYSE:TAK),(NASDAQ:CMPS),(NYSE:PFE),(NYSE:BMY) EQNX::TICKER_END

Via FinancialNewsMedia

Helus Pharma Appoints Former Pfizer Chief Medical Officer Dr. Freda Lewis-Hall to Board of Directors & Chair of the Scientific Advisory Committee

February 24, 2026

In this role, Dr. Lewis-Hall will guide clinical development strategy, regulatory engagement, and translational rigor across Helus’ novel serotonergic agonist (“NSA”) portfolio This news release...

Via FinancialNewsMedia

Pfizer Invites Public to Listen to Webcast of Pfizer Discussion at Healthcare Conference

February 23, 2026

From Pfizer Inc.

Via Business Wire

Pfizer’s BRAFTOVI Regimen Improves Progression-Free Survival in Metastatic Colorectal Cancer

February 17, 2026

From Pfizer Inc.

Via Business Wire

FDA Grants Priority Review for HYMPAVZI® (marstacimab) sBLA for the Treatment of Two Hemophilia A or B Patient Populations with Significant Medical Need

February 06, 2026

From Pfizer Inc.

Via Business Wire

< Previous 1 2 3 4 5 6 7 8 9

...

40 41 Next >

Stock Quote API & Stock News API supplied by www.cloudquote.io
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the Privacy Policy and Terms Of Service.